Molecular Pharmacology's market value is the price at which a share of Molecular Pharmacology trades on a public exchange. It measures the collective expectations of Molecular Pharmacology investors about its performance. Molecular Pharmacology is trading at 1.0E-4 as of the 26th of November 2024. This is a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Molecular Pharmacology and determine expected loss or profit from investing in Molecular Pharmacology over a given investment horizon. Check out Molecular Pharmacology Correlation, Molecular Pharmacology Volatility and Molecular Pharmacology Alpha and Beta module to complement your research on Molecular Pharmacology.
Please note, there is a significant difference between Molecular Pharmacology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Pharmacology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Pharmacology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Molecular Pharmacology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Molecular Pharmacology's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Molecular Pharmacology.
0.00
08/28/2024
No Change 0.00
0.0
In 3 months and 1 day
11/26/2024
0.00
If you would invest 0.00 in Molecular Pharmacology on August 28, 2024 and sell it all today you would earn a total of 0.00 from holding Molecular Pharmacology or generate 0.0% return on investment in Molecular Pharmacology over 90 days. Molecular Pharmacology is related to or competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, DiaMedica Therapeutics, Silo Pharma, and Molecular Partners. Molecular Pharmacology Limited, a development stage company, develops and commercializes pain and inflammation managemen... More
Molecular Pharmacology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Molecular Pharmacology's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Molecular Pharmacology upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Molecular Pharmacology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Molecular Pharmacology's standard deviation. In reality, there are many statistical measures that can use Molecular Pharmacology historical prices to predict the future Molecular Pharmacology's volatility.
Molecular Pharmacology has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11% return per unit of risk over the last 3 months. Molecular Pharmacology exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Molecular Pharmacology's Mean Deviation of 2.67, standard deviation of 11.23, and Risk Adjusted Performance of (0.05) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.17, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Molecular Pharmacology are expected to decrease at a much lower rate. During the bear market, Molecular Pharmacology is likely to outperform the market. At this point, Molecular Pharmacology has a negative expected return of -1.21%. Please make sure to verify Molecular Pharmacology's variance and kurtosis , to decide if Molecular Pharmacology performance from the past will be repeated at some point in the near future.
Correlation Coefficient
0.0
Spearman Rank Test
-0.21
Residual Average
0.0
Price Variance
0.0
Molecular Pharmacology lagged returns against current returns
Autocorrelation, which is Molecular Pharmacology pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Molecular Pharmacology's pink sheet expected returns. We can calculate the autocorrelation of Molecular Pharmacology returns to help us make a trade decision. For example, suppose you find that Molecular Pharmacology has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Molecular Pharmacology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Molecular Pharmacology pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Molecular Pharmacology pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Molecular Pharmacology pink sheet over time.
Current vs Lagged Prices
Timeline
Molecular Pharmacology Lagged Returns
When evaluating Molecular Pharmacology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Molecular Pharmacology pink sheet have on its future price. Molecular Pharmacology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Molecular Pharmacology autocorrelation shows the relationship between Molecular Pharmacology pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Molecular Pharmacology.
Other Information on Investing in Molecular Pink Sheet
Molecular Pharmacology financial ratios help investors to determine whether Molecular Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecular with respect to the benefits of owning Molecular Pharmacology security.